Top View
- The Addition of Avibactam Renders Piperacillin an Effective Treatment
- Ceftazidime-Avibactam Antimicrobial Activity When Tested Against Gram
- Antimicrobial Dosing Recommendations for Pediatric Patients (≥2 Months of Age and Post-Menstrual Age >44 Weeks’)
- Antimicrobial Guide
- Ceftazidime-Avibactam Versus Meropenem in Nosocomial
- Ceftazidime/Avibactam (Avycaz®) IV Only Use Requires Formal ID Consult
- Effect of Amoxicillin in Combination with Imipenem-Relebactam
- Guide to Antimicrobial Chemotherapy (PDF)
- Activity of Ceftazidime-Avibactam Versus Pseudomonas Aeruginosa, Including Multiple-Drug IHMA, Inc
- 20 Progress—Development of New Drugs Active Against Gram-Negative Bacilli: an Update from the Infectious Diseases Society of America
- 50 DISKS CARTRIDGE Study of Susceptibility to Antimicrobial Agents
- Ceftazidime-Avibactam
- Activity of Aztreonam Combined with the Beta-Lactamase Inhibitor Avibactam Tested Against Metallo-Β-Lactamase-Producing Organisms
- CLSI AST News Update Janet A
- Susceptibility Testing Β-Lactamase Inhibitor Combinations
- Activity of Ceftazidime-Avibactam Tested Against Clinical Isolates Of
- Structural/Mechanistic Insights Into the Efficacy of Nonclassical Β
- Ceftazidime-Avibactam Activity When Tested Against Gram-Negative
- In Vitro Activity of Ceftazidime–Avibactam and Comparators
- Expanded Antimicrobial Susceptibility Testing for Hard-To-Treat Infections
- Ceftazidime-Avibactam Plasma Levels in Critically Ill Patients, Including Those Receiving Continuous Renal Replacement Therapy
- AVYCAZ (Ceftazidime and Avibactam) for Injection, for Intravenous Use (Ml/Min) Initial U.S
- Ast Mastdiscs Flyer
- Zavicefta, INN-Avibactam and Ceftazidime
- Antimicrobial Dosing Recommendations for Adult Patients1
- VITEK®2 Gram-Negative Susceptibility Panels
- Ceftazidime/Avibactam (Avycaz™, Actavis) September 2015 Inpatient – Non-Formulary
- Old and New Beta-Lactamase Inhibitors: Molecular Structure, Mechanism of Action, and Clinical Use
- Pyelonephritis (Acute): Antimicrobial Prescribing NICE Guideline Draft for Consultation, May 2018
- New Carbapenemase Inhibitors: Clearing the Way for the -Lactams
- Activity of Ceftazidime-Avibactam Alone and in Combination with Ertapenem, Fosfomycin, and Tigecycline Against Carbapenemase-Producing Klebsiella Pneumoniae
- Antibiotics 201: Gram- Negatives Disclosures
- Ceftolozane-Tazobactam (J01DI54) Delafloxacin (J01MA23) Eravacycline (J01AA13) Meropenem-Vaborbactam (J01DH52) Omadacycline Plazomicin (J01GB14)
- Guideline Selective Reporting of Antimicrobials in Australia
- 36X56 Portrait
- Emergence and Recovery of Ceftazidime-Avibactam Resistance